| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 83-92, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
A Bellocq, M Antoine, A Flahault, C Philippe, B Crestani, JF Bernaudin, C Mayaud, B Milleron, L Baud and J Cadranel
Service d'Explorations Fonctionnelles, Hopital Tenon, Paris, France.
Tumor infiltrate, predominantly constituted by lymphocytes, may represent an important prognostic factor in bronchioloalveolar carcinoma (BAC), in addition to tumor extension and histological type. In the present study, we determined the presence, the origin, and the prognostic importance of neutrophils that also participate in leukocyte infiltrates of BAC. Neutrophil alveolitis was determined immunohistochemically in both lung biopsies and bronchoalveolar lavage (BAL) fluid samples from 29 patients with histologically proved BAC. The local expression of interleukin (IL)-8 was determined by immunohistochemical and immunoenzymatic techniques. Neutrophil counts were analyzed in relation to the clinical outcome of patients by the Kaplan-Meier method and Cox's univariate and stepwise multivariate models. Lymphocytes and neutrophils dominated the inflammatory cell population in the lower respiratory tract of patients with BAC. Neutrophils were located mainly in the alveolar lumen and seldom in alveolar wall whereas lymphocytes were exclusively present in alveolar wall. A relationship was observed between the number of neutrophils and the level of IL-8 in BAL fluid suggesting the involvement of that chemokine in neutrophil recruitment. The tumor cells were the predominant cells that appeared to express IL-8 by immunolocalization. The presence of increased numbers of neutrophils was significantly associated with a poorer outcome in patients with BAC (P = 0.02). In a multivariate analysis, the neutrophil percentage in BAL fluid was an independent predictor of clinical outcome. The risk of death was increased substantially (rate ratio, 5.2; 95% confidence interval, 1.1 to 24.7) among patients with BAL neutrophil percentage of > or = 39% (median of the distribution) as compared with the others. In BAC, neutrophils accumulate in the alveolar lumen. Elaboration of IL-8 by tumor cells may be responsible for this event, which is associated with a significantly higher risk of death.
This article has been cited by other articles:
![]() |
M. Hsu, S.-Y. Wu, S.-S. Chang, I.-J. Su, C.-H. Tsai, S.-J. Lai, A.-L. Shiau, K. Takada, and Y. Chang Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells J. Virol., April 1, 2008; 82(7): 3679 - 3688. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iwanaga, Y. Yang, M. G. Raso, L. Ma, A. E. Hanna, N. Thilaganathan, S. Moghaddam, C. M. Evans, H. Li, W.-W. Cai, et al. Pten Inactivation Accelerates Oncogenic K-ras-Initiated Tumorigenesis in a Mouse Model of Lung Cancer Cancer Res., February 15, 2008; 68(4): 1119 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shaykhiev and R. Bals Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis J. Leukoc. Biol., July 1, 2007; 82(1): 1 - 15. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, M. Antoine, N. Rabbe, V. Gounant, V. Poulot, A. Lavole, J. Fleury-Feith, and J. Cadranel Neutrophils Promote Aerogenous Spread of Lung Adenocarcinoma with Bronchioloalveolar Carcinoma Features Clin. Cancer Res., June 15, 2007; 13(12): 3518 - 3527. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. M. Dirkx, M. G. A. oude Egbrink, J. Wagstaff, and A. W. Griffioen Monocyte/macrophage infiltration in tumors: modulators of angiogenesis J. Leukoc. Biol., December 1, 2006; 80(6): 1183 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, N. Fujimoto, J. G. Izzo, A. E. Hanna, D. D. Cody, R. R. Langley, H. Tang, M. D. Burdick, M. Sato, J. D. Minna, et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res., April 15, 2006; 66(8): 4198 - 4207. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, W. Ouyang, and C. Huang Inflammation, a Key Event in Cancer Development Mol. Cancer Res., April 1, 2006; 4(4): 221 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de Perrot, S. Chernenko, T. K. Waddell, Y. Shargall, A. F. Pierre, M. Hutcheon, and S. Keshavjee Role of Lung Transplantation in the Treatment of Bronchogenic Carcinomas for Patients With End-Stage Pulmonary Disease J. Clin. Oncol., November 1, 2004; 22(21): 4351 - 4356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lantuejoul, T.V. Colby, G.R. Ferretti, P.Y. Brichon, C. Brambilla, and E. Brambilla Adenocarcinoma of the lung mimicking inflammatory lung disease with honeycombing Eur. Respir. J., September 1, 2004; 24(3): 502 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gerber, A. Heimburg, A. Reisenauer, A. Wille, T. Welte, and F. Buhling Proteasome inhibitors modulate chemokine production in lung epithelial and monocytic cells Eur. Respir. J., July 1, 2004; 24(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. U. Schraufstatter, K. Trieu, M. Zhao, D. M. Rose, R. A. Terkeltaub, and M. Burger IL-8-Mediated Cell Migration in Endothelial Cells Depends on Cathepsin B Activity and Transactivation of the Epidermal Growth Factor Receptor J. Immunol., December 15, 2003; 171(12): 6714 - 6722. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, M.-A. Massiani, B. Milleron, A. Souidi, M.-F. Carette, M. Antoine, and J. Cadranel Clinical Characteristics of Pneumonic-Type Adenocarcinoma of the Lung Chest, June 1, 2003; 123(6): 1868 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mukaida Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L566 - L577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, N. Rabbe, J. Marchal, B. Milleron, B. Crestani, C. Mayaud, M. Antoine, P. Soler, and J. Cadranel Hepatocyte Growth Factor Production by Neutrophils Infiltrating Bronchioloalveolar Subtype Pulmonary Adenocarcinoma: Role in Tumor Progression and Death Cancer Res., March 15, 2003; 63(6): 1405 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, J. Fleury-Feith, N. Rabbe, J. Moreau, D. Cesari, B. Milleron, C. Mayaud, M. Antoine, P. Soler, and J. Cadranel Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor Prolong the Survival of Neutrophils Infiltrating Bronchoalveolar Subtype Pulmonary Adenocarcinoma Am. J. Pathol., October 1, 2001; 159(4): 1423 - 1433. [Abstract] [Full Text] |
||||
![]() |
A. S. Haqqani, J. K. Sandhu, and H.C. Birnboim Constitutive expression of interleukin-8 by Mutatect cells markedly affects their tumor biology Carcinogenesis, February 1, 2001; 22(2): 243 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Call, J. A. Nemzek, S. J. Ebong, G. L. Bolgos, D. E. Newcomb, and D. G. Remick Ratio of Local to Systemic Chemokine Concentrations Regulates Neutrophil Recruitment Am. J. Pathol., February 1, 2001; 158(2): 715 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Sandhu, H. F. Privora, G. Wenckebach, and H. C. Birnboim Neutrophils, Nitric Oxide Synthase, and Mutations in the Mutatect Murine Tumor Model Am. J. Pathol., February 1, 2000; 156(2): 509 - 518. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |